The ICD-10 code for Maxillofacial Dysostosis is Q75.0. In ICD-9, it is represented by the code 756.0. Maxillofacial Dysostosis refers to a congenital condition characterized by abnormal development of the bones in the face and skull. It can lead to various facial abnormalities and functional impairments. Proper coding is essential for accurate medical record keeping and billing purposes.
Maxillofacial dysostosis is a congenital disorder characterized by abnormal development of the bones in the face and jaw region. It is also known as craniofacial dysostosis or Crouzon syndrome. This condition affects the growth of the skull, leading to various facial abnormalities such as a protruding forehead, wide-set eyes, and a beaked nose.
In the International Classification of Diseases, 10th Revision (ICD-10), maxillofacial dysostosis is classified under the code Q75.1. This code falls under the category of "Congenital malformations and deformations of the musculoskeletal system" (Q65-Q79). It specifically denotes "Craniofacial dysostosis" as the primary diagnosis.
On the other hand, in the previous version of the ICD, the 9th Revision (ICD-9), maxillofacial dysostosis is represented by the code 756.0. This code is found in the section "Congenital anomalies of face and neck" (ICD-9 codes 740-759).
It is important to note that the ICD-10 code provides more detailed and specific information compared to the ICD-9 code. The transition from ICD-9 to ICD-10 allows for improved accuracy and precision in medical coding, facilitating better tracking of diagnoses and treatments.
Maxillofacial dysostosis, or craniofacial dysostosis, requires proper medical evaluation, diagnosis, and management by a healthcare professional. Treatment options may include surgical interventions to correct facial abnormalities, orthodontic care, and supportive therapies to address any associated complications.